Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.32 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3377421 | 0.90 | CYP2D6 (0.40) | CYP2D6TAS1R3TAS1R1 | |
| SCHEMBL3373684 | 0.90 | TAS1R3 (0.35) | CYP2D6TAS1R3TAS1R1 | |
| SCHEMBL3375786 | 0.81 | CYP2D6 (0.38) | CYP2D6TAS1R3TAS1R1 | |
| SCHEMBL3376056 | 0.77 | — | — | |
| SCHEMBL3373122 | 0.69 | CYP2D6 (0.56) | CYP2D6 | |
| SCHEMBL3373137 | 0.68 | IDO1 (0.34) | CYP2D6 | |
| SCHEMBL4723853 | 0.68 | TAS1R3 (0.30) | TAS1R3TAS1R1 | |
| SCHEMBL3376835 | 0.68 | TAS1R3 (0.33) | CYP2D6TAS1R3TAS1R1 | |
| SCHEMBL22387077 | 0.68 | CYP2D6 (0.39) | CYP2D6 | |
| SCHEMBL23718456 | 0.64 | TAS1R3 (0.32) | TAS1R3TAS1R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100324091-A1 | Pyrazolone Derivative | KOWA COMPANY, LTD. (JP) | 2010-12-23 | — | — | US | disclosed |
| EP-2172458-A1 | PYRAZOLONE DERIVATIVE | Kowa Company, Ltd. (JP) | 2010-04-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100324091-A1 | Pyrazolone Derivative | SERPINE1, SERPINC1, TFPI | CYP2D6 1265/4885TAS1R3 1059/4885TAS1R1 745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.